Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Light Science Technologies' Injectaclad acquisition drives first major order

Light Science Technologies' Injectaclad acquisition drives first major order

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed its first order since acquiring Injectaclad — a £410,000 contract to supply fire protection materials for a five-storey residential building.

Deacon explains what sets Injectaclad apart: it eliminates the need to remove a building's façade, making it around ten times cheaper and six to seven times faster than traditional remediation, with no disruption to residents.

The commercial opportunity is substantial. The company is working with 11 installers nationwide, has a quoted pipeline of around £130 million, and is targeting a market of over 40,000 UK buildings requiring remedial fire protection work, with improving approval timelines from the Building Safety Regulator helping projects move faster.

For more insights like this, visit Proactive’s YouTube channel, like the video, subscribe, and enable notifications so you never miss future updates.

#LightScienceTechnologies #Injectaclad #FireSafety #Cladding #BuildingSafety #ConstructionUK #StockMarketNews #SmallCapStocks #Infrastructure #FireProtection #UKHousing #InvestorNews #CEOInterview

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK